PATENT CLAIM ANALYSIS

Application Number: 16241017
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "204100"]

Abstract:
Compositions and methods are provided for preventing or treating neoplastic disease in a mammalian subject. A composition is provided which comprises an enriched immune cell population reactive to a human endogenous retrovirus type E antigen on a tumor cell. A method of treating a neoplastic disease in a mammalian subject is provided which comprises administering to a mammalian subject a composition comprising an enriched immune cell population reactive to a human endogenous retrovirus type E antigen, in an amount effective to reduce or eliminate the neoplastic disease or to prevent its occurrence or recurrence.

Claim (Index 7):
The method of  claim 6 , wherein the CD8 +  T cell population or dendritic cells are an allogeneic cell population or an autologous cell population.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 99.0
- Lexical Diversity: 1.96
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14549296', '15821523', '12479415', '15200885', '14447341']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8220236182329407
- 35 USC 102 Novelty (BERT): 0.6325595761968998
- Combined Prediction Score: 0.8030772140293365
- Mean Citation Score: 517.4738140000002
- Max Citation Score: 753.4361
- Similarity Product: 520.9004297771694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test